Sorry, you need to enable JavaScript to visit this website.

Exact Sciences and Pfizer Enter into a U.S. Agreement for CologuardĀ®

October 8, 2018

On August 22, 2018, Exact Sciences Corp. and Pfizer Inc. announced an agreement to co-promote Cologuard, the FDA-approved non-invasive stool DNA screening test for colorectal cancer. Pfizer joins Exact Sciences' colleagues in reaching both physicians and health systems and also actively participates in extending and deepening the Cologuard development.

For further medical information, please call Exact Sciences Provider Support Line 1-844-870-8870